HB 1741Washington
Expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.
In committee
Jan 12, 2026: By resolution, reintroduced and retained in present status.